Product Information

VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1769 per EA under NDC 33342007710. Its NADAC has been published 649 times since Jun 18, 2014.

FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB

Valsartan and Hydrochlorothiazide
$0.1769per EA

Strength

12.5; 320 mg/1; mg/1

NDC

33342007710

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203145

FDA Approved

4/19/2013

TE Code

AB

On Market Since

4/19/2013

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB has been published 649 times since Jun 18, 2014, and over the history we have for it it has declined 48.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1769 per EA
All-time high$0.7070 (Dec 16, 2020)
All-time low$0.1769 (Nov 18, 2026)
52-week high$0.2274
52-week low$0.1769
Median price$0.2984
Average price$0.3269
Largest weekly change+57.9% (Jan 22, 2020)
Weeks tracked649
Tracking sinceJun 18, 2014

Price History

1W

-3.2%

1M

-4.9%

3M

-7.4%

6M

-10.7%

1Y

-22.2%

3Y

-33.7%

5Y

-63.9%

All

-48.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.1769 per EA (NDC 33342007710), effective Nov 18, 2026.

How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB has declined 48.3%. It has been tracked across 649 weekly CMS publications since Jun 18, 2014.

What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

Since Jun 18, 2014, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB has ranged from a low of $0.1769 (Nov 18, 2026) to a high of $0.7070 (Dec 16, 2020), with a median of $0.2984 per EA.

Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB?

VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB (NDC 33342007710) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.